Med-Progress Osrodek Nowoczesnego Leczenia Sp. z o.o.

The research at Med-Progress Osrodek Nowoczesnego Leczenia focuses on chronic heart failure and evaluates the benefit of ferric derisomaltose in iron‑deficient patients, aiming to improve survival and reduce hospital admissions.

• Efficacy of intravenous iron therapy in symptomatic heart failure
• Impact on cardiovascular mortality and hospitalizations

This work contributes to better management strategies for heart failure patients at the Wejherowo site.

Studies at the center address hyperuricemia associated with gout, testing the ability of dotinurad to lower serum uric acid levels compared with existing treatment, with the goal of improving disease control.

• Reduction of serum uric acid in gout patients
• Comparison of new therapy with standard allopurinol treatment

These investigations support enhanced therapeutic options for gout sufferers in the region.